XFOR Financial Statements

Balance sheet, income statement, cash flow, and dividends for X4 Pharmaceuticals Inc (XFOR).


$125.11M Market Cap.

As of 03/26/2025 5:00 PM ET (MRY) • Disclaimer

XFOR Market Cap. (MRY)


XFOR Shares Outstanding (MRY)


XFOR Assets (MRY)


Total Assets

$146.45M

Total Liabilities

$124.30M

Total Investments

$46.36M

XFOR Income (MRY)


Revenue

$2.56M

Net Income

-$37.45M

Operating Expense

$38.16M

XFOR Cash Flow (MRY)


CF Operations

-$130.90M

CF Investing

$66.99M

CF Financing

$20.29M

XFOR Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

XFOR Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$146,447,000 (-0.55%)

$147,258,000 (-5.35%)

$155,586,000 (32.78%)

$117,176,000 (-4.63%)

Assets Current

$112,175,000 (-8.11%)

$122,076,000 (-5.13%)

$128,677,000 (46.43%)

$87,878,000 (5.49%)

Assets Non-Current

$34,272,000 (36.10%)

$25,182,000 (-6.42%)

$26,909,000 (-8.15%)

$29,298,000 (-25.95%)

Goodwill & Intangible Assets

$27,351,000 (57.63%)

$17,351,000 (0.00%)

$17,351,000 (0.00%)

$17,351,000 (-36.00%)

Shareholders Equity

$22,149,000 (-56.65%)

$51,099,000 (-30.99%)

$74,051,000 (14.96%)

$64,412,000 (-11.52%)

Property Plant & Equipment Net

$4,841,000 (-24.30%)

$6,395,000 (-23.26%)

$8,333,000 (-18.50%)

$10,224,000 (11.17%)

Cash & Equivalents

$55,699,000 (-43.86%)

$99,216,000 (-18.49%)

$121,718,000 (48.82%)

$81,787,000 (3.91%)

Accumulated Other Comprehensive Income

-$122,000 (-2.52%)

-$119,000 (0.00%)

-$119,000 (0.00%)

-$119,000 (0.00%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$46,361,000 (209.07%)

$15,000,000 (0%)

$0 (0%)

$0 (0%)

Investments Current

$46,361,000 (209.07%)

$15,000,000 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$2,817,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$1,710,000 (204.27%)

$562,000 (-51.22%)

$1,152,000 (54.22%)

$747,000 (-18.54%)

Trade & Non-Trade Payables

$8,621,000 (-3.64%)

$8,947,000 (15.04%)

$7,777,000 (81.58%)

$4,283,000 (36.23%)

Accumulated Retained Earnings (Deficit)

-$515,355,000 (-7.84%)

-$477,905,000 (-26.85%)

-$376,738,000 (-33.18%)

-$282,871,000 (-45.68%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$78,086,000 (33.98%)

$58,281,000 (51.69%)

$38,420,000 (-3.43%)

$39,785,000 (3.48%)

Debt Current

$1,251,000 (13.83%)

$1,099,000 (-56.27%)

$2,513,000 (34.39%)

$1,870,000 (137.91%)

Debt Non-Current

$76,835,000 (34.37%)

$57,182,000 (59.25%)

$35,907,000 (-5.30%)

$37,915,000 (0.67%)

Total Liabilities

$124,298,000 (29.26%)

$96,159,000 (17.94%)

$81,535,000 (54.53%)

$52,764,000 (5.38%)

Liabilities Current

$32,877,000 (43.81%)

$22,862,000 (2.41%)

$22,324,000 (59.20%)

$14,023,000 (17.37%)

Liabilities Non-Current

$91,421,000 (24.73%)

$73,297,000 (23.79%)

$59,211,000 (52.84%)

$38,741,000 (1.62%)

XFOR Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$2,557,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$797,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$61,518,000 (73.27%)

$35,505,000 (31.40%)

$27,020,000 (9.38%)

$24,702,000 (17.95%)

Research & Development Expense

$81,643,000 (13.37%)

$72,017,000 (17.95%)

$61,058,000 (20.56%)

$50,647,000 (20.78%)

Operating Expenses

$38,161,000 (-64.51%)

$107,522,000 (22.79%)

$87,569,000 (2.89%)

$85,107,000 (35.36%)

Interest Expense

$8,768,000 (51.77%)

$5,777,000 (44.68%)

$3,993,000 (9.64%)

$3,642,000 (35.49%)

Income Tax Expense

$310,000 (297.44%)

$78,000 (178.57%)

$28,000 (64.71%)

$17,000 (-88.51%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$37,450,000 (62.98%)

-$101,167,000 (-7.78%)

-$93,867,000 (-5.83%)

-$88,696,000 (-42.76%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$37,450,000 (62.98%)

-$101,167,000 (-7.78%)

-$93,867,000 (-5.83%)

-$88,696,000 (-42.76%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$2,546,000 (-81.74%)

$13,943,000 (0%)

Net Income Common Stock

-$37,450,000 (62.98%)

-$101,167,000 (-4.93%)

-$96,413,000 (6.07%)

-$102,639,000 (-65.20%)

Weighted Average Shares

$201,062,211 (13.08%)

$177,812,480 (179.91%)

$63,526,000 (146.71%)

$25,749,000 (28.25%)

Weighted Average Shares Diluted

$201,062,211 (13.08%)

$177,812,480 (179.91%)

$63,526,000 (146.71%)

$25,749,000 (28.25%)

Earning Before Interest & Taxes (EBIT)

-$28,372,000 (70.23%)

-$95,312,000 (-6.08%)

-$89,846,000 (-5.66%)

-$85,037,000 (-43.41%)

Gross Profit

$1,760,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$36,401,000 (66.15%)

-$107,522,000 (-22.79%)

-$87,569,000 (-2.89%)

-$85,107,000 (-42.14%)

XFOR Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$66,990,000 (550.11%)

-$14,883,000 (-14349.51%)

-$103,000 (83.25%)

-$615,000 (54.85%)

Net Cash Flow from Financing

$20,294,000 (-77.07%)

$88,516,000 (-24.49%)

$117,230,000 (57.90%)

$74,245,000 (499.04%)

Net Cash Flow from Operations

-$130,901,000 (-35.63%)

-$96,512,000 (-25.17%)

-$77,102,000 (-8.74%)

-$70,905,000 (-20.55%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$43,773,000 (-92.16%)

-$22,780,000 (-157.06%)

$39,920,000 (1559.19%)

$2,406,000 (105.08%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$74,316,000 (601.36%)

-$14,823,000 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$7,326,000 (-12110.00%)

-$60,000 (41.75%)

-$103,000 (83.25%)

-$615,000 (54.85%)

Issuance (Repayment) of Debt Securities

$20,000,000 (-2.13%)

$20,436,000 (2670.57%)

-$795,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$294,000 (-99.57%)

$68,711,000 (-41.79%)

$118,037,000 (58.98%)

$74,245,000 (26042.61%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$156,000 (-257.58%)

$99,000 (194.29%)

-$105,000 (67.08%)

-$319,000 (-179.35%)

Share Based Compensation

$8,204,000 (-5.56%)

$8,687,000 (67.09%)

$5,199,000 (-15.87%)

$6,180,000 (13.85%)

Depreciation Amortization & Accretion

$2,381,000 (19.29%)

$1,996,000 (0.10%)

$1,994,000 (5.39%)

$1,892,000 (53.82%)

XFOR Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

68.80%

-

-

-

Profit Margin

-1464.60%

-

-

-

EBITDA Margin

-1016.50%

-

-

-

Return on Average Equity (ROAE)

-84.50% (50.32%)

-170.10% (4.87%)

-178.80% (-41.79%)

-126.10% (-95.81%)

Return on Average Assets (ROAA)

-23.10% (64.68%)

-65.40% (23.78%)

-85.80% (-12.89%)

-76.00% (-68.89%)

Return on Sales (ROS)

-1109.60%

-

-

-

Return on Invested Capital (ROIC)

-31.10% (84.61%)

-202.10% (26.46%)

-274.80% (-43.57%)

-191.40% (-11.93%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-3.86 (-162.47%)

-1.47 (-125.27%)

-0.65 (-13.76%)

-0.57 (72.42%)

Price to Sales Ratio (P/S)

57.68

-

-

-

Price to Book Ratio (P/B)

5.65 (105.79%)

2.75 (195.80%)

0.93 (5.69%)

0.88 (-38.99%)

Debt to Equity Ratio (D/E)

5.61 (198.19%)

1.88 (70.94%)

1.1 (34.43%)

0.82 (19.04%)

Earnings Per Share (EPS)

-0.19 (66.67%)

-0.57 (62.50%)

-1.52 (61.90%)

-3.99 (-29.13%)

Sales Per Share (SPS)

0.01 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.69 (-26.52%)

-0.54 (55.31%)

-1.22 (56.26%)

-2.78 (7.31%)

Book Value Per Share (BVPS)

0.11 (-61.67%)

0.29 (-75.39%)

1.17 (-53.40%)

2.5 (-31.00%)

Tangible Assets Book Value Per Share (TABVPS)

0.59 (-19.02%)

0.73 (-66.41%)

2.18 (-43.87%)

3.88 (-18.72%)

Enterprise Value Over EBIT (EV/EBIT)

-4 (-300.00%)

-1 (0%)

0 (0%)

0 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

-4.08 (-467.55%)

-0.72 (-131.61%)

-0.31 (-28.63%)

-0.24 (70.14%)

Asset Turnover

0.02 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

3.41 (-36.10%)

5.34 (-7.36%)

5.76 (-8.03%)

6.27 (-10.11%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$138,227,000 (-43.13%)

-$96,572,000 (-25.09%)

-$77,205,000 (-7.95%)

-$71,520,000 (-18.84%)

Enterprise Value (EV)

$105,903,890 (58.12%)

$66,978,679 (146.13%)

$27,212,428 (35.84%)

$20,032,487 (-57.27%)

Earnings Before Tax (EBT)

-$37,140,000 (63.26%)

-$101,089,000 (-7.73%)

-$93,839,000 (-5.82%)

-$88,679,000 (-43.07%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$25,991,000 (72.15%)

-$93,316,000 (-6.22%)

-$87,852,000 (-5.66%)

-$83,145,000 (-43.19%)

Invested Capital

$108,606,000 (64.28%)

$66,110,000 (102.71%)

$32,613,000 (-25.54%)

$43,800,000 (0.56%)

Working Capital

$79,298,000 (-20.07%)

$99,214,000 (-6.71%)

$106,353,000 (44.00%)

$73,855,000 (3.50%)

Tangible Asset Value

$119,096,000 (-8.32%)

$129,907,000 (-6.02%)

$138,235,000 (38.48%)

$99,825,000 (4.24%)

Market Capitalization

$125,112,890 (-10.81%)

$140,273,679 (104.03%)

$68,750,428 (21.51%)

$56,581,487 (-45.97%)

Average Equity

$44,314,250 (-25.49%)

$59,476,000 (10.30%)

$53,921,750 (-33.73%)

$81,372,750 (-15.72%)

Average Assets

$161,851,250 (4.70%)

$154,588,750 (37.52%)

$112,409,000 (-16.79%)

$135,096,750 (-2.15%)

Invested Capital Average

$91,207,500 (93.38%)

$47,166,000 (44.27%)

$32,692,500 (-26.41%)

$44,423,000 (28.11%)

Shares

170,546,469 (1.95%)

167,291,209 (141.63%)

69,235,074 (180.21%)

24,708,073 (51.71%)